Ekso Bionics Holdings, Inc. (LON:0IFR)

Market Cap	25.88M +128.2%
Revenue (ttm)	10.97M -16.6%
Net Income	-7.93M
EPS	-3.90
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	591
Average Volume	2,110
Open	4.249
Previous Close	4.498
Day's Range	4.249 - 4.270
52-Week Range	3.685 - 22.639
Beta	1.88
RSI	35.17
Earnings Date	Mar 4, 2026

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 66
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IFR

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Financial numbers in USD